ANTI-INSULIN ANTIBODY - ANVISA Registration 80867150116

Access comprehensive regulatory information for ANTI-INSULIN ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80867150116 and manufactured by SHENZHEN YHLO BIOTECH CO., LTD.. The registration is held by BIOMOLECULAR TECHNOLOGY COMÉRCIO, IMPORTAÇÃO, EXPORTAÇÃO E DISTRIBUIÇÃO DE MATERIAIS MÉDICOS E LABORATORIAIS LTDA - EPP with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including MEDIPAN, ORGENTEC DIAGNOSTIKA GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80867150116
Registration Details
ANVISA Registration Number: 80867150116
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

AUTOIMMUNE DIABETES MULTI CONTROL
Risk Class II

Registration Details

80867150116

25351801496202115

07767477000146

Dates and Status

Jul 29, 2021

VIGENTE

09/18/2025 19:00:01